Santoni, M.; Heng, D.Y.; Bracarda, S.; Procopio, G.; Milella, M.; Porta, C.; Matrana, M.R.; Cartenì, G.; Crabb, S.J.; De Giorgi, U.;
et al. Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors. Cancers 2020, 12, 84.
https://doi.org/10.3390/cancers12010084
AMA Style
Santoni M, Heng DY, Bracarda S, Procopio G, Milella M, Porta C, Matrana MR, Cartenì G, Crabb SJ, De Giorgi U,
et al. Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors. Cancers. 2020; 12(1):84.
https://doi.org/10.3390/cancers12010084
Chicago/Turabian Style
Santoni, Matteo, Daniel Y. Heng, Sergio Bracarda, Giuseppe Procopio, Michele Milella, Camillo Porta, Marc R. Matrana, Giacomo Cartenì, Simon J. Crabb, Ugo De Giorgi,
and et al. 2020. "Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors" Cancers 12, no. 1: 84.
https://doi.org/10.3390/cancers12010084
APA Style
Santoni, M., Heng, D. Y., Bracarda, S., Procopio, G., Milella, M., Porta, C., Matrana, M. R., Cartenì, G., Crabb, S. J., De Giorgi, U., Basso, U., Masini, C., Calabrò, F., Vitale, M. G., Santini, D., Massari, F., Galli, L., Fornarini, G., Ricotta, R.,
... Battelli, N.
(2020). Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors. Cancers, 12(1), 84.
https://doi.org/10.3390/cancers12010084
